Annals of Surgical Oncology

, Volume 24, Issue 12, pp 3732–3740 | Cite as

Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer

  • Shinya Okumura
  • Toshimi Kaido
  • Yuhei Hamaguchi
  • Atsushi Kobayashi
  • Hisaya Shirai
  • Siyuan Yao
  • Shintaro Yagi
  • Naoko Kamo
  • Etsuro Hatano
  • Hideaki Okajima
  • Kyoichi Takaori
  • Shinji Uemoto
Pancreatic Tumors



Visceral fat accumulation and muscle depletion have been identified as poor prognostic factors for various cancers. However, the significance of visceral adiposity and sarcopenic visceral obesity on outcomes after resection of pancreatic cancer remains unclear.


A retrospective analysis of 301 patients who underwent resection for localized pancreatic cancer between 2004 and 2015 was performed. The extent of visceral adiposity [visceral to subcutaneous adipose tissue area ratio (VSR)] and visceral obesity [visceral fat area (VFA)] were measured on preoperative computed tomography images, together with skeletal muscle index (SMI) and muscle attenuation (MA). The impacts of these body composition parameters on outcomes after pancreatic resection were investigated.


The overall survival (OS) and recurrence-free survival (RFS) rates in patients with high VSR were significantly lower than those in patients with low VSR (P = 0.001, P = 0.007, respectively). There were no differences in OS and RFS between high VFA and low VFA group; however, when analyzed together with sarcopenic factors, OS and RFS rates of the patients with sarcopenic visceral obesity were significantly lower compared with those of the others. Multivariate analyses revealed that high VSR was an independent risk factor for mortality (hazard ratio (HR) 1.58, P = 0.009) and recurrence (HR 1.41, P = 0.026) together with low SMI, low MA, high CA19-9, microvascular invasion, and nodal metastasis.


Visceral adiposity and sarcopenic visceral obesity, as well as low muscle mass and quality, were closely associated with mortality and recurrence after resection of pancreatic cancer.



The authors thank Ms. Sayaka Tokuda, Ms. Yukiko Shimizu, Ms. Noriko Watanabe, Ms. Yu Aimi, and Ms. Mayumi Kawashima at Kyoto University Hospital for their kind help in collecting clinical data.


The authors declare that there are no conflicts of interest in relation to this study. No financial support was received from any source for this study.

Supplementary material

10434_2017_6077_MOESM1_ESM.docx (134 kb)
Supplementary material 1 (DOCX 133 kb)


  1. 1.
    Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.CrossRefPubMedGoogle Scholar
  2. 2.
    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.CrossRefPubMedGoogle Scholar
  3. 3.
    Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364:1817–25.CrossRefPubMedGoogle Scholar
  4. 4.
    Mathur A, Luberice K, Paul H, Franka C, Rosemurgy A. Increasing body mass index portends abbreviated survival following pancreatoduodenectomy for pancreatic adenocarcinoma. Am J Surg. 2015;209:969–73.CrossRefPubMedGoogle Scholar
  5. 5.
    Peng P, Hyder O, Firoozmand A, et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg. 2012;16:1478–86.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007;298:2028–37.CrossRefPubMedGoogle Scholar
  7. 7.
    van Kruijsdijk RC, van der Wall E, Visseren FL. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomark Prev. 2009;18:2569–78.CrossRefGoogle Scholar
  8. 8.
    Fujiwara N, Nakagawa H, Kudo Y, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 2015;63:131–40.CrossRefPubMedGoogle Scholar
  9. 9.
    Moon HG, Ju YT, Jeong CY, et al. Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol. 2008;15:1918–22.CrossRefPubMedGoogle Scholar
  10. 10.
    Okamura A, Watanabe M, Mine S, et al. Clinical impact of abdominal fat distribution on prognosis after esophagectomy for esophageal squamous cell carcinoma. Ann Surg Oncol. 2016;23:1387–94.CrossRefPubMedGoogle Scholar
  11. 11.
    Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on sarcopenia in older people. Age Ageing. 2010;39:412–23.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15:95–101.CrossRefPubMedGoogle Scholar
  13. 13.
    Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics.” Clin Nutr. 2010;29:154–59.CrossRefPubMedGoogle Scholar
  14. 14.
    van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg. 2012;99:550–57.CrossRefPubMedGoogle Scholar
  15. 15.
    Kaido T, Ogawa K, Fujimoto Y, et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant. 2013;13:1549–56.CrossRefPubMedGoogle Scholar
  16. 16.
    Voron T, Tselikas L, Pietrasz D, et al. Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg. 2015;261:1173–83.CrossRefPubMedGoogle Scholar
  17. 17.
    Marcus RL, Addison O, Kidde JP, Dibble LE, Lastayo PC. Skeletal muscle fat infiltration: impact of age, inactivity, and exercise. J Nutr Health Aging. 2010;14:362–36.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Zoico E, Corzato F, Bambace C, et al. Myosteatosis and myofibrosis: relationship with aging, inflammation and insulin resistance. Arch Gerontol Geriatr. 2013;57:411–16.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Hamaguchi Y, Kaido T, Okumura S, et al. Preoperative intramuscular adipose tissue content is a novel prognostic predictor after hepatectomy for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2015;22:475–85.CrossRefPubMedGoogle Scholar
  20. 20.
    Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629–35.CrossRefPubMedGoogle Scholar
  21. 21.
    Nishigori T, Tsunoda S, Okabe H, et al. Impact of sarcopenic obesity on surgical site infection after laparoscopic total gastrectomy. Ann Surg Oncol. 2016;23:524–31.CrossRefPubMedGoogle Scholar
  22. 22.
    Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg. 2004;240:205–13.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33:997–1006.CrossRefPubMedGoogle Scholar
  24. 24.
    Matsuzawa Y. New criteria for ‘obesity disease’ in Japan. Circ J. 2002;66:987–92.CrossRefGoogle Scholar
  25. 25.
    Okumura S, Kaido T, Hamaguchi Y, et al. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery. 2015;157:1088–98.CrossRefPubMedGoogle Scholar
  26. 26.
    Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8:457–65.CrossRefPubMedGoogle Scholar
  27. 27.
    Cao Y. Angiogenesis modulates adipogenesis and obesity. J Clin Investig. 2007;117:2362–28.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010;11:11–18.CrossRefPubMedGoogle Scholar
  29. 29.
    Lutz CT, Quinn LS. Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism. Aging.. 2012;4:535–46.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    White PB, True EM, Ziegler KM, et al. Insulin, leptin, and tumoral adipocytes promote murine pancreatic cancer growth. J Gastrointest Surg. 2010;14:1888–93; discussion 93–94.CrossRefPubMedGoogle Scholar
  31. 31.
    Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6:772–83.CrossRefPubMedGoogle Scholar
  32. 32.
    Targher G, Rossi AP, Zamboni GA, et al. Pancreatic fat accumulation and its relationship with liver fat content and other fat depots in obese individuals. J Endocrinol Invest. 2012;35:748–53.PubMedGoogle Scholar
  33. 33.
    Mathur A, Zyromski NJ, Pitt HA, et al. Pancreatic steatosis promotes dissemination and lethality of pancreatic cancer. J Am Coll Surg. 2009;208:989–94; discussion 94–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Kaido T, Tamai Y, Hamaguchi Y, et al. Effects of pretransplant sarcopenia and sequential changes in sarcopenic parameters after living donor liver transplantation. Nutrition. 2017;33:195–98.CrossRefPubMedGoogle Scholar
  35. 35.
    Benzo R, Wigle D, Novotny P, et al. Preoperative pulmonary rehabilitation before lung cancer resection: results from two randomized studies. Lung Cancer. 2011;74:441–45.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Mayo NE, Feldman L, Scott S, et al. Impact of preoperative change in physical function on postoperative recovery: argument supporting prehabilitation for colorectal surgery. Surgery. 2011;150:505–14.CrossRefPubMedGoogle Scholar
  37. 37.
    Keating SE, Hackett DA, Parker HM, et al. Effect of aerobic exercise training dose on liver fat and visceral adiposity. J Hepatol. 2015;63:174–82.CrossRefPubMedGoogle Scholar
  38. 38.
    Hutton JL, Martin L, Field CJ, et al. Dietary patterns in patients with advanced cancer: implications for anorexia-cachexia therapy. Am J Clin Nutr. 2006;84:1163–70.PubMedGoogle Scholar
  39. 39.
    Bozzetti F, Mariani L. Perioperative nutritional support of patients undergoing pancreatic surgery in the age of ERAS. Nutrition. 2014;30:1267–71.CrossRefPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2017

Authors and Affiliations

  • Shinya Okumura
    • 1
  • Toshimi Kaido
    • 1
  • Yuhei Hamaguchi
    • 1
  • Atsushi Kobayashi
    • 1
  • Hisaya Shirai
    • 1
  • Siyuan Yao
    • 1
  • Shintaro Yagi
    • 1
  • Naoko Kamo
    • 1
  • Etsuro Hatano
    • 1
  • Hideaki Okajima
    • 1
  • Kyoichi Takaori
    • 1
  • Shinji Uemoto
    • 1
  1. 1.Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of MedicineKyoto UniversityKyotoJapan

Personalised recommendations